Invivyd Chairman to Advocate for Monoclonal Antibody Role at POLITICO Health Care Summit

Event summary

  • Invivyd Chairman Marc Elia will speak at the POLITICO Health Care Summit on April 21, 2026, from 11:30 AM to 12:00 PM ET.
  • The summit, featuring speakers like Mehmet Oz and Mark Cuban, focuses on the future of American healthcare.
  • Elia's session will address the evolving role of monoclonal antibodies in viral disease prevention.
  • The event will be live-streamed between 9:00 AM and 1:00 PM ET.

The big picture

Invivyd's Chairman's participation in this high-profile summit signals a strategic effort to shape the narrative around preventative medicine and advocate for a greater role for monoclonal antibodies. This comes as the U.S. healthcare system re-evaluates its approach to infectious disease preparedness following recent public health crises, and as the company seeks to expand beyond its initial SARS-CoV-2 focus. The summit provides a platform to influence policy and potentially secure favorable regulatory conditions for future antibody development.

What we're watching

Policy Influence
How Elia's advocacy at the summit will influence the ongoing debate regarding federal stewardship versus private sector innovation in infectious disease prevention remains to be seen.
Market Adoption
Whether the broader acceptance of monoclonal antibodies as a preventative measure, beyond vaccines, can significantly expand Invivyd’s addressable market and revenue streams warrants close observation.
Competitive Response
The response from competitors like Cost Plus Drugs, who advocate for alternative pricing models, to Invivyd’s positioning on preventative monoclonal antibodies will likely shape the competitive dynamics of the market.

Related topics

Public Health